AXTI vs. ARWR
AXTI (AXT, Inc.) and ARWR (Arrowhead Pharmaceuticals, Inc.) are both stocks. AXTI operates in Semiconductor Equipment & Materials (Technology), while ARWR operates in Biotechnology (Healthcare). Over the past 10 years, AXTI returned 32.89%/yr vs 29.30%/yr for ARWR. At a 0.15 correlation, their price movements are largely independent.
Performance
AXTI vs. ARWR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AXTI achieves a 249.91% return, which is significantly higher than ARWR's 15.08% return. Over the past 10 years, AXTI has outperformed ARWR with an annualized return of 32.89%, while ARWR has yielded a comparatively lower 29.30% annualized return.
AXTI
- 1D
- -8.54%
- 1M
- -41.13%
- 6M
- 148.85%
- YTD
- 249.91%
- 1Y
- 2,500.45%
- 3Y*
- 172.09%
- 5Y*
- 40.63%
- 10Y*
- 32.89%
ARWR
- 1D
- -9.05%
- 1M
- 2.52%
- 6M
- 18.34%
- YTD
- 15.08%
- 1Y
- 317.26%
- 3Y*
- 30.61%
- 5Y*
- 2.62%
- 10Y*
- 29.30%
AXTI vs. ARWR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AXTI AXT, Inc. | 249.91% | 653.46% | -9.58% | -45.21% | -50.28% | -7.94% | 120.00% | -0.00% | -50.00% | 81.25% |
ARWR Arrowhead Pharmaceuticals, Inc. | 15.08% | 253.14% | -38.56% | -24.56% | -38.82% | -13.59% | 20.97% | 410.71% | 237.50% | 137.42% |
Correlation
The correlation between AXTI and ARWR is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since May 21, 1998 | 0.15 |
The correlation between AXTI and ARWR shifts across timeframes, from 0.14 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
AXTI:
$2.65B
ARWR:
$10.76B
AXTI:
-$0.30
ARWR:
-$2.16
AXTI:
28.19
ARWR:
17.15
AXTI:
11.24
ARWR:
18.17
AXTI:
$95.89M
ARWR:
$622.01M
AXTI:
$20.46M
ARWR:
$529.27M
AXTI:
-$7.63M
ARWR:
-$168.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AXTI vs. ARWR — Risk / Return Rank
AXTI
ARWR
AXTI vs. ARWR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AXT, Inc. (AXTI) and Arrowhead Pharmaceuticals, Inc. (ARWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AXTI | ARWR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +12.81 | ||
| Sortino ratioReturn per unit of downside risk | +0.89 | ||
| Omega ratioGain probability vs. loss probability | 1.64 | 1.55 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 41.21 | 12.47 | +28.74 |
| Martin ratioReturn relative to average drawdown | 131.50 | 34.27 | +97.23 |
Loading charts...
Drawdowns
AXTI vs. ARWR - Drawdown Comparison
The maximum AXTI drawdown since its inception was -98.57%, roughly equal to the maximum ARWR drawdown of -99.24%. Use the drawdown chart below to compare losses from any high point for AXTI and ARWR.
Loading charts...
Drawdown Indicators
| AXTI | ARWR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.57% | -99.24% | +0.67% |
Max Drawdown (1Y)Largest decline over 1 year | -59.80% | -24.64% | -35.16% |
Max Drawdown (3Y)Largest decline over 3 years | -78.52% | -74.70% | -3.82% |
Max Drawdown (5Y)Largest decline over 5 years | -88.79% | -87.89% | -0.90% |
Max Drawdown (10Y)Largest decline over 10 years | -92.45% | -88.96% | -3.49% |
Current DrawdownCurrent decline from peak | -59.38% | -52.98% | -6.40% |
Average DrawdownAverage peak-to-trough decline | -82.18% | -81.13% | -1.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.70% | 8.96% | +9.74% |
Volatility
AXTI vs. ARWR - Volatility Comparison
AXT, Inc. (AXTI) has a higher volatility of 43.25% compared to Arrowhead Pharmaceuticals, Inc. (ARWR) at 15.30%. This indicates that AXTI's price experiences larger fluctuations and is considered to be riskier than ARWR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AXTI | ARWR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 43.25% | 15.30% | +27.95% |
Volatility (6M)Calculated over the trailing 6-month period | 115.92% | 35.06% | +80.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 141.47% | 65.65% | +75.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 97.58% | 64.04% | +33.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.53% | 74.16% | +9.37% |
Dividends
AXTI vs. ARWR - Dividend Comparison
Neither AXTI nor ARWR has paid dividends to shareholders.
Financials
AXTI vs. ARWR - Financials Comparison
This section allows you to compare key financial metrics between AXT, Inc. and Arrowhead Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AXTI and ARWR have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXTI has higher volatility (43.25%) compared to ARWR (15.30%). In terms of maximum drawdown, AXTI dropped -98.57% vs ARWR's -99.24%.
AXTI currently has the higher Sharpe Ratio (17.49 vs 4.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AXTI and ARWR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer